Automobile stocks such as Tata Motors, Maruti Suzuki, Hyundai Motor India, Ashok Leyland, Eicher Motors, Mahindra & Mahindra, Escorts, TVS Motor Company, Bajaj Auto, Hero Moto Corp, Ather Energy, Ola Electric, and others will remain in focus as they announce May sales figures from today.

Analysts tracking the Vahan portal (registration portal) expect robust sales figures from automobile companies.

Shares of textile and apparel stocks such as Vardhman Textiles, Arvind Ltd, Ambika Cotton Mills, KPR Mills, Page Industries, Indo Count Industries, Kiltex Garments and others will remain in focus as the Ministry of Finance has suspended the import duty on cotton from June 1 to October 31, giving the much-sought relief for the textile industry.

In a notification issued on May 30, the Ministry said the 11 % duty will not be levied from June 1.

Export Levy cut The Central government has revised export levies on petrol, diesel and aviation turbine fuel (ATF) for the fortnight beginning June 1.

The duty has been set at ₹1.5 per litre on petrol exports, ₹13.5 per litre on diesel exports and ₹9.5 per litre on ATF exports, as per an official notification.

The special additional excise duty (SAED) on petrol at Rs 3 per litre was imposed on May 16.

The duty on export of diesel has been reduced from Rs 16.5 per litre, and for ATF from Rs 16 per litre.

Reliance Industries, ONGC, Chennai Petroleum Corporation, MRPL and Indian Oil.

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for sodium sulfate, magnesium sulfate, and potassium chloride tablets, 1.479 g/0.225 g/0.188 g.

Sodium sulfate, magnesium sulfate, and potassium chloride tablets (RLD Sutab) had an estimated annual sale of USD 132.8 million in the US (IQVIA MAT March 2026).

Wockhardt has secured US FDA approval for Zaynich (cefepime and zidebactam) for the treatment of complicated urinary tract infections.

Phase 3 trials showed an efficacy rate of 89% compared to 68.4% for meropenem.